Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation
A new catheter from Johnson & Johnson MedTech is now approved to treat cardiac arrhythmias in Europe. Could FDA approval be on the horizon?
Robotic mitral repair compares favorably to surgery—but some concerns remain
Robotic-assisted mitral valve repair is associated with short-term outcomes comparable to conventional surgery, according to a new analysis of more than 40,000 patients. Robotic treatment also helps patients spend less time in the hospital, but the costs are much higher.
FDA has now cleared more than 1,000 AI models, including many in cardiology
Cardiology is the medical speciality with the second most FDA clearances overall.
Altered brain structure may play a role in eating disorders, MRI data suggest
Experts recently uncovered evidence suggesting behaviors such as undereating, binging and purging could be owed to anatomical alterations in parts of the brain.
Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston,

Biosense Webster shares latest data on its pulsed field ablation system

The company, part of Johnson & Johnson MedTech, shared positive data from two different clinical trials at AF Symposium 2024 in Boston.

February 5, 2024

Francisco Arabia, MD, Banner Health, explains trends in total artificial hearts (TAH) in advanced heart failure patients and what is coming in new technology.

Total artificial hearts: Exploring the future of heart transplant technology with a renowned surgeon

Francisco Arabia, MD, spoke with Cardiovascular Business about the present and future of total artificial heart technology.

February 5, 2024

Procyrion's Aortix percutaneous mechanical circulatory support (pMCS) device

Heart failure specialists raise $58M for new device designed to improve cardiac, renal function

Researchers are presently tracking the safety and effectiveness of the new device in patients with ADHF compared to diuretics alone.

February 5, 2024

CDC: Updated COVID jab significantly reduces odds of infection

The latest COVID-19 vaccine began entering recipients’ bodies last September. Now comes early CDC data supporting the formulation’s general effectiveness.

February 4, 2024

Harvard professor accused of doctoring images used in decades of research

A total of 28 studies have been flagged as potentially fraudulent, with some published as early as 2001.

February 2, 2024

Thinner gray matter ribbons signal dementia risk

Researchers examined decade-old MR images from Framingham Heart Study participants to develop their observation.

February 2, 2024

Targeting the left atrial posterior wall during pulsed field ablation fails to improve outcomes

Researchers explored the potential of an alternate way to perform PFA on patients with persistent AFib, presenting their findings live at AF Symposium 2024 in Boston.

February 2, 2024

FDA approves first transcatheter tricuspid valve replacement device, the EVOQUE system from Edwards Lifesciences

Edwards makes history, receives FDA approval for transcatheter tricuspid valve replacement device

The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation.

February 2, 2024

Clinical

Johnson & Johnson gains CE mark approval for catheter capable of radiofrequency, PFA ablation

Robotic mitral repair compares favorably to surgery—but some concerns remain

FDA has now cleared more than 1,000 AI models, including many in cardiology

Altered brain structure may play a role in eating disorders, MRI data suggest

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications